Zusammenfassung
Anders als die Antibiotika-Forschung steht die Erforschung des Folsäure-Stoffwechsels und der Folsäure-Antagonisten ganz in der klassischen aufPaul Ehrlich zurückgehenden Tradition der Chemotherapie. Mit der Aufklärung des Wirkungsmechanismus der Sulfonamide wurde eine wichtige Voraussetzung zum Verständnis der Biosynthese der Folsäure geschaffen. Die Synthese von Inhibitoren der Dihydrofolat-Reduktase orientierte sich einerseits an der Struktur der Dihydrofolsäure selbst, andererseits an der Tatsache, daß diese Substanz für bestimmte Bakterien einen lebenswichtigen Wuchsstoff darstellt. Beide Arbeitsrichtungen führten zu wirksamen und therapeutisch verwendbaren Verbindungen. Die Mechanismen der Selektivität der Folsäure-Antagonisten werden geschildert. Ebenso werden die biochemischen und genetischen Grundlagen der Resistenz gegen Folsäure-Antagonisten beschrieben. Die Erforschung des Folsäure-Stoffwechsels und der Folsäure-Antagonisten liefert ein eindrucksvolles Beispiel für die erfolgreiche Wechselwirkung zwischen einer mechanistisch inspirierten biochemischen und chemischen Methodik einerseits und einer sich an komplexeren biologischen Phänomenen orientierenden empirischen Arbeitsweise andererseits.
Summary
In contrast to antibiotic research, the study of folic acid metabolism and folic acid antagonists is conducted in the classical tradition of chemotherapy established byPaul Ehrlich. The elucidation of the mechanism of action of sulphonamides created an important prerequisite for the understanding of the biosynthesis of folic acid. The synthesis of inhibitors of dihydrofolate-reductase was guided on the one hand by the structure of dihydrofolate itself, and on the other hand by the fact that this substance is essential for the growth of certain bacteria. Both approaches led to the synthesis of compounds which were effective and could be used therapeutically. The mechanism of selectivity of folic acid antagonists is described. A short account of the biochemical and genetic basis of resistance to folic acid antagonists is also given. The study of folic acid metabolism and folic acid antagonists provides a good example of the successful interaction of mechanistically inspired biochemical and chemical methods on the one hand, and an empirical approach characterised by the study of more complex biological phenomena on the other hand.
Literatur
Domagk, G. Ein Beitrag zur Chemotherapie der bakteriellen Infektionen. Dtsch. Med. Wschr. 61 (1935) 250–253.
Farber, S., Diamond, L. K., Mercer, R. D., Sylvester, R. F., Jr., Wolff, J. A. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin). N. Engl. J. Med. 238 (1948) 787–793.
Angier, R. B., Boothe, J. H., Hutchings, B. L., Mowat, J. H., Semb, J., Stockstad, E. L. R., Subbarow, Y., Waller, C. W., Cosulich, D. B., Fahrenbach, M. J., Hultwuist, M. E., Kuh, E., Northey, E. H., Seeger, D. R., Sickels, J. P., Smith, J. M. Jr. The structure and synthesis of the liverL. casei factor. Science 103 (1947) 667–669.
Ehrlich, P. Gesammelte Arbeiten. Springer, Berlin 1957.
Tréfouël, J., Tréfouël, J., Nitti, F., Bovet, D. Activié du p-aminophénylsulfamide sur les infections streptococciques expérimentales de la souris et du lapin. C. R. Soc. Biol. (Paris) 120 (1935) 756–758.
Colebrook, L., Buttle, G. A. H., O'Meara, R. A. Q. The mode of action of p-aminobenzenesulphonamide and prontosil in haemolytic streptococcal infections. Lancet II (1936) 1323–1326.
Woods, D. D. The relation of p-aminobenzoic acid to the mechanism of the action of sulphanilamide. Br. J. Exp. Pathol. 21 (1940) 74–90.
Mitchell, H. K., Snell, E. E., Williams, R. J. The concentration of „folic acid“. J. Am. Chem. Soc. 63 (1941) 2284.
Korte, F., Rangachari, P. N., Scharf, H.-D. Die Folsäuregruppe. In:Ammon, R., Dirscherl, W. (Hrsg.): Fermente — Hormone — Vitamine und die Beziehungen dieser Wirkstoffe zueinander. Band III/1. Georg Thieme, Stuttgart 1974, S. 808–835.
Brown, G. M., Weisman, R. A., Molnar, D. A. The biosynthesis of folic acid. I. Substrate and cofactor requirements for enzymatic synthesis by cell-free extracts ofEscherichia coli. J. Biol. Chem. 236 (1961) 2534–2543.
Bock, L., Miller, G. H., Schaper, K.-J., Seidel, J. K. Sulfonamide structure-activity relationships in a cell-free system. 2. Proof for the formation of a sulfonamide containing folate analog. J. Med. Chem. 17 (1974) 23–28.
Hitchings, G. H., Falco, E. A., Vanderwerff, H., Russell, P. B., Elion, G. B. Antagonists of nucleic acid derivatives. VII. 2,4-Diaminopyrimidines. J. Biol. Chem. 199 (1952) 43–56.
Hertz, R., Lewis, J., Lippsett, M. B. 5 years experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women. Am. J. Obstet. Gynec. 82 (1961) 631–640.
Burchall, J. J., Hitchings, G. H. Inhibitor binding analysis of dihydrofolate reductases from various species. Mol. Pharmacol. 1 (1965) 126–136.
Hitchings, G. H., Burchall, J. J., Ferone, R. The comparative enzymology of dihydrofolate reductase and the design of chemotherapeutic agents. In: Biochemical Studies of Antimicrobial Drugs. 16th Symposium of the Society for General Microbiology, London 1966. University Press, Cambridge 1966, S. 294–300.
Burchall, J. J. Enzyme inhibitors as antimicrobial agents. In:Drews, J., Hahn, F. E. (Hrsg.): Topics in infectious diseases. Vol. 1: Drug receptor interactions in antimicrobial chemotherapy. Springer, Wien-New York 1975, S. 285–293.
Bertino, J. R. Folate antagonists. In:Sartorelli, A. C., Johns, D. G. (Hrsg.): Handbook of experimental pharmacology XXXVIII/2. Antineoplastic and immunosuppressive agents Part II. Springer, Berlin-Heidelberg-New York 1975, S. 468–483.
Ensminger, W. D., Grindey, G. B., Hoglind, J. A. Antifolate therapy. Rescue, selective host protection, and drug combinations. In:Rosowsky, A. (Hrsg.): Advances in cancer chemotherapy Vol. 1. Marcel Dekker Inc., New York-Basel, 1979, S. 61–109.
Burchenal, J. H., Rabcock, G. M. Prevention of toxicity of massive doses of amethopterin by citrovorum factor. Proc. Soc. Exp. Biol. 76 (1951) 382–384.
Finland, M., Kass, E. H. Conference on trimethoprim-sulfamethoxazole. Summary and comments on the conference. J. Infect. Dis. 128 Suppl. (1973) S 792-S 816.
Greenberg, J., Richeson, E. M. Effect of 2,4-diamino-5-(p-chlorophenoxy)-6-methylpyrimidine and 2,4-diamino-6,7-diphenylpteridine on chlorguanide-resistant strain ofPlasmodium gallinaceum. Proc. Soc. Exp. Biol. 77 (1951) 174–176.
Bushby, S. R. M., Hitchings, G. H. Trimethoprim, a sulphonamide potentiator. Br. J. Pharmacol. Chemother. 33 (1968) 72–90.
Huovinen, P., Toivanen, P. Trimethoprim resistance in Finland after five years' use of plain trimethoprim. Br. Med. J. 280 (1980) 72–74.
Black, M. L. Sequential blockage as a theoretical basis for drug synergism. J. Med. Chem. 6 (1963) 145–153.
Bertino, J. R., Skeel, R. T. Resistance to chemotherapeutic agents: Clinical aspects. Proc. 5th Int. Congress Pharmacology 3 (1973) 376–392.
Hrynink, W. M., Bertino, J. R. The treatment of leukemia with large doses of methotrexate and folinic acid: Clinical-biochemical correlates. J. Clin. Invest. 48 (1969) 2140–2155.
Sirotnak, F. M., Donati, G. J., Hutchison, D. J. Evidence for a genetic alteration of dihydrofolate reductase associated with amethopterin resistance inDiplococcus pneumoniae. Biochem. Biophys. Res. Commun. 14 (1964) 292–295.
Amyes, S. G. B., Smith, J. T. R-Factor trimethoprim resistance mechanism: An insusceptible target site. Biochem. Biophys. Res. Commun. 58 (1974) 412–418.
Sköld, O., Widh, A. A new dihydrofolate reductase with low trimethoprim sensitivity induced by an R factor mediating high resistance to trimethoprim. J. Biol. Chem. 249 (1974) 4324–4325.
Wise, E. M., Jr., Abou-Donia, M. M. Sulfonamide resistance mechanism inEscherichia coli: R plasmids can determine sulfonamide-resistant dihydropteroate synthases. Proc. Natl. Acad. Sci. U.S.A. 72 (1975) 2621–2625.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Drews, J. Hemmstoffe des Folsäure-Stoffwechsels. Infection 8 (Suppl 3), S268–S275 (1980). https://doi.org/10.1007/BF01639593
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01639593